NDC11 85424001401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 85424-0014-01 | 85424-0014 |
| 85424-0014-1 | 85424-0014 |
| 85424-014-01 | 85424-014 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream | SALICYLIC ACID 3% | RoyceDerm LLC | 496e178b-e29b-071e-e063-6394a90aa018 | 2026-08-13 | Warnings | 85424-014-01 85424-014 85424001401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.